» Articles » PMID: 38468637

Incidence of Post-Transplant Malignancies in Thai Adult Kidney Transplant Recipients: A Single-Center, Population-Controlled, Retrospective Cohort Study at the Highest Volume Kidney Transplant Center in Thailand

Overview
Journal Transpl Int
Specialty General Surgery
Date 2024 Mar 12
PMID 38468637
Authors
Affiliations
Soon will be listed here.
Abstract

Kidney transplant recipients (KTRs) are at increased risk of developing post-transplant malignancies (PTMs), with regional differences in types with excess risk compared to the general population. A single-center, population-controlled, retrospective cohort study was conducted at a tertiary care center in Thailand among all adults who underwent their first kidney transplant from 1986 to 2018. Standardized incidence ratios (SIRs) of malignancy by age, sex, and place of residence were obtained using data from the National Cancer Registry of Thailand as population control. There were 2,024 KTRs [mean age, 42.4 years (SD 11.4); female patients, 38.6%] during 16,495 person-years at risk. Of these, 125 patients (6.2%) developed 133 PTMs. The SIR for all PTMs was 3.85 (95% CI 3.22, 4.56), and for pooled solid and hematologic PTMs, it was 3.32 (95% CI 2.73, 3.99). Urothelial malignancies had the largest excess risk, especially in women [female SIR 114.7 (95% CI 66.8, 183.6); male SIR 17.5 (95% CI 8.72, 31.2)]. The next two most common cancers were non-Hodgkin's lymphoma and skin cancer [SIR 20.3 (95% CI 13.6, 29.1) and 24.7 (95% CI 15.3-37.8), respectively]. Future studies are needed to identify the risk factors and assess the need for systematic screening among PTMs with excess risk in KTRs.

Citing Articles

Post-Kidney Transplant Cancer: A Real-World Retrospective Analysis From a Single Italian Center.

Re Sarto G, Alfieri C, Cosmai L, Brigati E, Campise M, Regalia A Transpl Int. 2024; 37:13220.

PMID: 39228659 PMC: 11368674. DOI: 10.3389/ti.2024.13220.

References
1.
Yanik E, Clarke C, Snyder J, Pfeiffer R, Engels E . Variation in Cancer Incidence among Patients with ESRD during Kidney Function and Nonfunction Intervals. J Am Soc Nephrol. 2015; 27(5):1495-504. PMC: 4849829. DOI: 10.1681/ASN.2015040373. View

2.
Sirirungreung A, Buasom R, Jiraphongsa C, Sangrajrang S . Data Reliability and Coding Completeness of Cancer Registry Information Using Reabstracting Method in the National Cancer Institute: Thailand, 2012 to 2014. J Glob Oncol. 2018; 4:1-9. PMC: 6223438. DOI: 10.1200/JGO.17.00147. View

3.
Kasiske B, Snyder J, Gilbertson D, Wang C . Cancer after kidney transplantation in the United States. Am J Transplant. 2004; 4(6):905-13. DOI: 10.1111/j.1600-6143.2004.00450.x. View

4.
Krishnan A, Wong G, Teixeira-Pinto A, Lim W . Incidence and Outcomes of Early Cancers After Kidney Transplantation. Transpl Int. 2022; 35:10024. PMC: 9110645. DOI: 10.3389/ti.2022.10024. View

5.
Ashoor I, Beyl R, Gupta C, Jain A, Kiessling S, Moudgil A . Low-Dose Antithymocyte Globulin Has No Disadvantages to Standard Higher Dose in Pediatric Kidney Transplant Recipients: Report From the Pediatric Nephrology Research Consortium. Kidney Int Rep. 2021; 6(4):995-1002. PMC: 8071617. DOI: 10.1016/j.ekir.2021.01.007. View